Tianeptine modulates amygdalar glutamate neurochemistry and synaptic proteins in rats subjected to repeated stress

Experimental Neurology

Volumn 241, Issue 1, 2013, Pages 184-193

  Piroli, Gerardo G ^a   Reznikov, Leah R ^a   Grillo, Claudia A ^a   Hagar, Janel M ^a   Fadel, Jim R ^a   Reagan, Lawrence P ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Basolateral amygdala; Central amygdala; In vivo microdialysis; SNAP 25; VGLUT2

Indexed keywords

GLUTAMIC ACID; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TIANEPTINE; VESICULAR GLUTAMATE TRANSPORTER 2;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; IMMOBILIZATION STRESS; IN VIVO STUDY; MALE; MICRODIALYSIS; MOLECULAR DOCKING; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TREATMENT DURATION;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUTAMIC ACID; IMMUNOPRECIPITATION; MALE; MEMBRANE PROTEINS; MICRODIALYSIS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; THIAZEPINES; TIME FACTORS;

EID: 84872867806     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.12.005     Document Type: Article

References (62)

1. Altamura C.A., Mauri M.C., Ferrara A., Moro A.R., D'Andrea G., Zamberlan F. Plasma and platelet excitatory amino acids in psychiatric disorders. Am. J. Psychiatry 1993, 150:1731-1733.
2. Altamura C., Maes M., Dai J., Meltzer H.Y. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur. Neuropsychopharmacol. 1995, 5:71-75. (Suppl.).
3. Auer D.P., Putz B., Kraft E., Lipinski B., Schill J., Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry 2000, 47:305-313.
4. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., Kavalali E.T., Monteggia L.M. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95.
5. Bagley J., Moghaddam B. Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam. Neuroscience 1997, 77:65-73.
6. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 2000, 47:351-354.
7. Bonanno G., Giambelli R., Raiteri L., Tiraboschi E., Zappettini S., Musazzi L., Raiteri M., Racagni G., Popoli M. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J. Neurosci. 2005, 25:3270-3279.
8. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000, 157:115-118.
9. Campbell S., Marriott M., Nahmias C., MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 2004, 161:598-607.
10. Charney D.S. Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 1998, 59(Suppl. 14):11-14.
11. Choi D.C., Evanson N.K., Furay A.R., Ulrich-Lai Y.M., Ostrander M.M., Herman J.P. The anteroventral bed nucleus of the stria terminalis differentially regulates hypothalamic-pituitary-adrenocortical axis responses to acute and chronic stress. Endocrinology 2008, 149:818-826.
12. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58:545-553.
13. Frodl T., Meisenzahl E., Zetzsche T., Bottlender R., Born C., Groll C., Jager M., Leinsinger G., Hahn K., Moller H.J. Enlargement of the amygdala in patients with a first episode of major depression. Biol. Psychiatry 2002, 51:708-714.
14. Gao Y., Bezchlibnyk Y.B., Sun X., Wang J.F., McEwen B.S., Young L.T. Effects of restraint stress on the expression of proteins involved in synaptic vesicle exocytosis in the hippocampus. Neuroscience 2006, 141:1139-1148.
15. Gilabert-Juan J., Castillo-Gomez E., Perez-Rando M., Molto M.D., Nacher J. Chronic stress induces changes in the structure of interneurons and in the expression of molecules related to neuronal structural plasticity and inhibitory neurotransmission in the amygdala of adult mice. Exp. Neurol. 2011, 232:33-40.
16. Grillo C.A., Piroli G.G., Wood G.E., Reagan L.P., McEwen B.S. Radioimmunocytochemical analysis of synaptic proteins provides a reliable measure of morphological changes in the rat hippocampus. Soc. Neurosci. Abstr. 2003, 33.
17. Guirado R., Sanchez-Matarredona D., Varea E., Crespo C., Blasco-Ibanez J.M., Nacher J. Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. BMC Neurosci. 2012, 13:5.
18. Hamidi M., Drevets W.C., Price J.L. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol. Psychiatry 2004, 55:563-569.
19. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996, 29:2-11.
20. Huttner W.B., Schiebler W., Greengard P., De Camilli P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J. Cell Biol. 1983, 96:1374-1388.
21. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
22. Kim J.S., Schmid-Burgk W., Claus D., Kornhuber H.H. Increased serum glutamate in depressed patients. Arch. Psychiatr. Nervenkr. 1982, 232:299-304.
23. LeDoux J.E., Farb C., Ruggiero D.A. Topographic organization of neurons in the acoustic thalamus that project to the amygdala. J. Neurosci. 1990, 10:1043-1054.
24. Levine J., Panchalingam K., Rapoport A., Gershon S., McClure R.J., Pettegrew J.W. Increased cerebrospinal fluid glutamine levels in depressed patients. Biol. Psychiatry 2000, 47:586-593.
25. Li N., Liu R.J., Dwyer J.M., Banasr M., Lee B., Son H., Li X.Y., Aghajanian G., Duman R.S. Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry 2011, 69:754-761.
26. McDonald A.J., Shammah-Lagnado S.J., Shi C., Davis M. Cortical afferents to the extended amygdala. Ann. N. Y. Acad. Sci. 1999, 877:309-338.
27. McEwen B.S. Mood disorders and allostatic load. Biol. Psychiatry 2003, 54:200-207.
28. McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur. J. Pharmacol. 2008, 583:174-185.
29. McEwen B.S., Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur. Neuropsychopharmacol. 2004, 14(Suppl. 5):S497-S502.
30. McEwen B.S., Magarinos A.M., Reagan L.P. Structural plasticity and tianeptine: cellular and molecular targets. Eur. Psychiatry 2002, 17(Suppl. 3):318-330.
31. McEwen B.S., Chattarji S., Diamond D.M., Jay T.M., Reagan L.P., Svenningsson P., Fuchs E. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol. Psychiatry 2010, 15:237-249.
32. Mirza Y., Tang J., Russell A., Banerjee S.P., Bhandari R., Ivey J., Rose M., Moore G.J., Rosenberg D.R. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:341-348.
33. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 1993, 60:1650-1657.
34. Muller H.K., Wegener G., Popoli M., Elfving B. Differential expression of synaptic proteins after chronic restraint stress in rat prefrontal cortex and hippocampus. Brain Res. 2011, 1385:26-37.
35. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13290-13295.
36. Paxinos G., Watson C. The Rat Brain in Sterotaxic Coordinates 1998, Academic Press.
37. Piroli G.G., Grillo C.A., Hoskin E.K., Znamensky V., Katz E.B., Milner T.A., McEwen B.S., Charron M.J., Reagan L.P. Peripheral glucose administration stimulates the translocation of GLUT8 glucose transporter to the endoplasmic reticulum in the rat hippocampus. J. Comp. Neurol. 2002, 452:103-114.
38. Piroli G.G., Grillo C.A., Reznikov L.R., Adams S., McEwen B.S., Charron M.J., Reagan L.P. Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 2007, 85:71-80.
39. Pitkanen A., Savander V., LeDoux J.E. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 1997, 20:517-523.
40. Price R.B., Nock M.K., Charney D.S., Mathew S.J. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol. Psychiatry 2009, 66:522-526.
41. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 1999, 45:1085-1098.
42. Raudensky J., Yamamoto B.K. Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Res. 2007, 1135:129-135.
43. Reagan L.P., Magariños A.M., Yee D.K., Szweda L.I., Van Bueren A., McCall A.L., McEwen B.S. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res. 2000, 862:292-300.
44. Reagan L.P., Rosell D.R., Wood G.E., Spedding M., Munoz C., Rothstein J., McEwen B.S. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2179-2184.
45. Reagan L.P., Hendry R.M., Reznikov L.R., Piroli G.G., Wood G.E., McEwen B.S., Grillo C.A. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur. J. Pharmacol. 2007, 565:68-75.
46. Reznikov L.R., Grillo C.A., Piroli G.G., Pasumarthi R.K., Reagan L.P., Fadel J. Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment. Eur. J. Neurosci. 2007, 25:3109-3114.
47. Reznikov L.R., Reagan L.P., Fadel J.R. Activation of phenotypically distinct neuronal subpopulations in the anterior subdivision of the rat basolateral amygdala following acute and repeated stress. J. Comp. Neurol. 2008, 508:458-472.
48. Reznikov L.R., Reagan L.P., Fadel J.R. Effects of acute and repeated restraint stress on GABA efflux in the rat basolateral and central amygdala. Brain Res. 2009, 1256:61-68.
49. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., Krystal J.H., Mason G.F. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 2004, 61:705-713.
50. Sheline Y.I., Gado M.H., Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998, 9:2023-2028.
51. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 1999, 19:5034-5043.
52. Singewald N., Kouvelas D., Mostafa A., Sinner C., Philippu A. Release of glutamate and GABA in the amygdala of conscious rats by acute stress and baroreceptor activation: differences between SHR and WKY rats. Brain Res. 2000, 864:138-141.
53. Thome J., Pesold B., Baader M., Hu M., Gewirtz J.C., Duman R.S., Henn F.A. Stress differentially regulates synaptophysin and synaptotagmin expression in hippocampus. Biol. Psychiatry 2001, 50:809-812.
54. Timmerman W., Cisci G., Nap A., De Vries J.B., Westerink B.H. Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysis. Brain Res. 1999, 833:150-160.
55. Turner B.H., Herkenham M. Thalamoamygdaloid projections in the rat: a test of the amygdala's role in sensory processing. J. Comp. Neurol. 1991, 313:295-325.
56. Varea E., Castillo-Gomez E., Gomez-Climent M.A., Blasco-Ibanez J.M., Crespo C., Martinez-Guijarro F.J., Nacher J. Chronic antidepressant treatment induces contrasting patterns of synaptophysin and PSA-NCAM expression in different regions of the adult rat telencephalon. Eur. Neuropsychopharmacol. 2007, 17:546-557.
57. Varea E., Guirado R., Gilabert-Juan J., Marti U., Castillo-Gomez E., Blasco-Ibanez J.M., Crespo C., Nacher J. Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients. J. Psychiatr. Res. 2012, 46:189-197.
58. von Gunten A., Fox N.C., Cipolotti L., Ron M.A. A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. J. Neuropsychiatry Clin. Neurosci. 2000, 12:493-498.
59. Vouimba R.M., Munoz C., Diamond D.M. Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 2006, 9:29-40.
60. Watanabe Y., Gould E., Daniels D.C., Cameron H., McEwen B.S. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur. J. Pharmacol. 1992, 222:157-162.
61. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., Manji H.K. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.
62. Zavala J.K., Fernandez A.A., Gosselink K.L. Female responses to acute and repeated restraint stress differ from those in males. Physiol. Behav. 2011, 104:215-221.